GMO Product Platform（3695）株式概要GMOプロダクトプラットフォーム株式会社は、日本、アジア、そして世界で視聴者参加型のプラットフォームを提供しています。 詳細3695 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績4/6財務の健全性5/6配当金4/6報酬当社が推定した公正価値より66.9%で取引されている 過去1年間で収益は1625%増加しました リスク分析過去5年間で収益は年間11.7%減少しました。 意味のある時価総額がありません ( ¥8B )不安定な配当実績 すべてのリスクチェックを見る3695 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueJP¥Current PriceJP¥1.73k22.9% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture012b2016201920222025202620282031Revenue JP¥12.4bEarnings JP¥682.8mAdvancedSet Fair ValueView all narrativesGMO Product Platform, Inc. 競合他社InterspaceLtdSymbol: TSE:2122Market cap: JP¥8.0bKyodo Public RelationsSymbol: TSE:2436Market cap: JP¥8.8bHYOJITOSymbol: TSE:7368Market cap: JP¥8.1bMaterial GroupSymbol: TSE:156AMarket cap: JP¥7.4b価格と性能株価の高値、安値、推移の概要GMO Product Platform過去の株価現在の株価JP¥1,726.0052週高値JP¥2,775.0052週安値JP¥1,582.00ベータ0.0641ヶ月の変化2.25%3ヶ月変化0.94%1年変化-32.89%3年間の変化-44.50%5年間の変化-17.06%IPOからの変化-64.27%最新ニュースReported Earnings • May 13First quarter 2026 earnings released: EPS: JP¥43.61 (vs JP¥41.01 loss in 1Q 2025)First quarter 2026 results: EPS: JP¥43.61 (up from JP¥41.01 loss in 1Q 2025). Revenue: JP¥2.00b (up 52% from 1Q 2025). Net income: JP¥192.0m (up JP¥259.0m from 1Q 2025). Profit margin: 9.6% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to JP¥1,706, the stock trades at a trailing P/E ratio of 48.5x. Average trailing P/E is 16x in the Media industry in Japan. Total loss to shareholders of 38% over the past three years.New Risk • Feb 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Share price has been volatile over the past 3 months (5.5% average weekly change). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥8.10b market cap, or US$52.8m).Reported Earnings • Feb 11Full year 2025 earnings released: EPS: JP¥41.66 (vs JP¥112 in FY 2024)Full year 2025 results: EPS: JP¥41.66 (down from JP¥112 in FY 2024). Revenue: JP¥6.82b (up 36% from FY 2024). Net income: JP¥155.0m (down 15% from FY 2024). Profit margin: 2.3% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.New Risk • Feb 11New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.3% Last year net profit margin: 3.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥9.03b market cap, or US$59.0m).お知らせ • Feb 10GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026.最新情報をもっと見るRecent updatesReported Earnings • May 13First quarter 2026 earnings released: EPS: JP¥43.61 (vs JP¥41.01 loss in 1Q 2025)First quarter 2026 results: EPS: JP¥43.61 (up from JP¥41.01 loss in 1Q 2025). Revenue: JP¥2.00b (up 52% from 1Q 2025). Net income: JP¥192.0m (up JP¥259.0m from 1Q 2025). Profit margin: 9.6% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to JP¥1,706, the stock trades at a trailing P/E ratio of 48.5x. Average trailing P/E is 16x in the Media industry in Japan. Total loss to shareholders of 38% over the past three years.New Risk • Feb 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Share price has been volatile over the past 3 months (5.5% average weekly change). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥8.10b market cap, or US$52.8m).Reported Earnings • Feb 11Full year 2025 earnings released: EPS: JP¥41.66 (vs JP¥112 in FY 2024)Full year 2025 results: EPS: JP¥41.66 (down from JP¥112 in FY 2024). Revenue: JP¥6.82b (up 36% from FY 2024). Net income: JP¥155.0m (down 15% from FY 2024). Profit margin: 2.3% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.New Risk • Feb 11New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.3% Last year net profit margin: 3.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥9.03b market cap, or US$59.0m).お知らせ • Feb 10GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026.お知らせ • Dec 27GMO Product Platform, Inc. to Report Fiscal Year 2025 Results on Feb 10, 2026GMO Product Platform, Inc. announced that they will report fiscal year 2025 results on Feb 10, 2026Upcoming Dividend • Dec 22Upcoming dividend of JP¥34.58 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 23 March 2026. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 1.6%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (1.7%).お知らせ • Dec 17GMO Product Platform, Inc. (TSE:3695) agreed to acquire 53.60% stake in STOCK POINT Inc. from Credit Saison Co., Ltd. (TSE:8253), KITS Co., Ltd and Kiyomi Tsuchiya for approximately ¥360 million.GMO Product Platform, Inc. (TSE:3695) agreed to acquire 53.60% stake in STOCK POINT Inc. from Credit Saison Co., Ltd. (TSE:8253), KITS Co., Ltd and Kiyomi Tsuchiya for approximately ¥360 million on December 15, 2025. A cash consideration of ¥361 million will be paid by GMO Product Platform, Inc. The scheduled contract execution date is December 16, 2025. Prior to the share transfer execution date, we may acquire additional shares of STOCK POINT Inc. held by other individuals and corporations. In this case, the maximum acquisition price will be ¥564 million, and the maximum number of shares to be acquired will be 1,324 shares and the maximum ownership ratio will be 82.5%. Additional disclosure is planned once the acquisition price and number of shares for the additional acquisition are finalized. For the period ending March 31, 2025, STOCK POINT Inc. reported total revenue of ¥374.18 million, operating loss of ¥231.81 million and net income of ¥200.21 million. As of March 31, 2025, STOCK POINT Inc. reported total assets of ¥2.28 billion and total common equity of ¥214.51 million. The expected completion of the transaction is December 26, 2025.Buy Or Sell Opportunity • Dec 04Now 21% overvaluedOver the last 90 days, the stock has fallen 2.4% to JP¥2,159. The fair value is estimated to be JP¥1,782, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.4% over the last 3 years. Earnings per share has declined by 48%.Reported Earnings • Nov 15Third quarter 2025 earnings released: EPS: JP¥23.99 (vs JP¥8.57 loss in 3Q 2024)Third quarter 2025 results: EPS: JP¥23.99 (up from JP¥8.57 loss in 3Q 2024). Revenue: JP¥1.75b (up 47% from 3Q 2024). Net income: JP¥106.0m (up JP¥120.0m from 3Q 2024). Profit margin: 6.1% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.お知らせ • Sep 17GMO Research & AI, Inc. to Report Q3, 2025 Results on Nov 12, 2025GMO Research & AI, Inc. announced that they will report Q3, 2025 results on Nov 12, 2025Reported Earnings • Aug 08Second quarter 2025 earnings released: EPS: JP¥12.67 (vs JP¥12.24 loss in 2Q 2024)Second quarter 2025 results: EPS: JP¥12.67 (up from JP¥12.24 loss in 2Q 2024). Revenue: JP¥1.85b (up 68% from 2Q 2024). Net income: JP¥56.0m (up JP¥76.0m from 2Q 2024). Profit margin: 3.0% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.お知らせ • Jun 27GMO Research & AI, Inc. to Report Q2, 2025 Results on Aug 07, 2025GMO Research & AI, Inc. announced that they will report Q2, 2025 results on Aug 07, 2025New Risk • May 17New major risk - Revenue and earnings growthEarnings have declined by 0.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Dividend per share is over 7x earnings per share. Cash payout ratio: 447% Earnings have declined by 0.4% per year over the past 5 years. Shareholders have been substantially diluted in the past year (169% increase in shares outstanding). Minor Risks Profit margins are more than 30% lower than last year (0.5% net profit margin). Market cap is less than US$100m (JP¥11.1b market cap, or US$76.0m).Reported Earnings • May 17First quarter 2025 earnings released: JP¥41.01 loss per share (vs JP¥56.35 profit in 1Q 2024)First quarter 2025 results: JP¥41.01 loss per share (down from JP¥56.35 profit in 1Q 2024). Revenue: JP¥1.32b (down 3.2% from 1Q 2024). Net loss: JP¥67.0m (down 173% from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has remained flat, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • May 15Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to JP¥2,374, the stock trades at a trailing P/E ratio of 57.1x. Average trailing P/E is 17x in the Media industry in Japan. Total returns to shareholders of 4.5% over the past three years.New Risk • Apr 18New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 169% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 103% Cash payout ratio: 447% Shareholders have been substantially diluted in the past year (169% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (3.6% net profit margin). Market cap is less than US$100m (JP¥12.2b market cap, or US$85.7m).分析記事 • Apr 09Returns On Capital At GMO Research & AI (TSE:3695) Paint A Concerning PictureWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...お知らせ • Mar 08GMO Research & AI, Inc. to Report Q1, 2025 Results on May 12, 2025GMO Research & AI, Inc. announced that they will report Q1, 2025 results on May 12, 2025New Risk • Feb 15New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 127% Cash payout ratio: 166% Dividend yield: 4.1% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.6% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 127% Cash payout ratio: 166% Minor Risks Profit margins are more than 30% lower than last year (3.6% net profit margin). Market cap is less than US$100m (JP¥4.57b market cap, or US$30.0m).Reported Earnings • Feb 14Full year 2024 earnings released: EPS: JP¥112 (vs JP¥188 in FY 2023)Full year 2024 results: EPS: JP¥112 (down from JP¥188 in FY 2023). Revenue: JP¥5.03b (down 1.8% from FY 2023). Net income: JP¥183.0m (down 40% from FY 2023). Profit margin: 3.6% (down from 6.0% in FY 2023). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.分析記事 • Feb 13GMO Research & AI, Inc.'s (TSE:3695) 25% Share Price Surge Not Quite Adding UpGMO Research & AI, Inc. ( TSE:3695 ) shares have had a really impressive month, gaining 25% after a shaky period...分析記事 • Feb 13Subdued Growth No Barrier To GMO Research & AI, Inc. (TSE:3695) With Shares Advancing 25%GMO Research & AI, Inc. ( TSE:3695 ) shares have had a really impressive month, gaining 25% after a shaky period...New Risk • Feb 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (127% payout ratio). Share price has been volatile over the past 3 months (7.5% average weekly change). Profit margins are more than 30% lower than last year (3.0% net profit margin). Market cap is less than US$100m (JP¥4.69b market cap, or US$30.5m).Valuation Update With 7 Day Price Move • Feb 13Investor sentiment improves as stock rises 20%After last week's 20% share price gain to JP¥2,870, the stock trades at a trailing P/E ratio of 31.7x. Average trailing P/E is 17x in the Media industry in Japan. Total returns to shareholders of 38% over the past three years.お知らせ • Feb 12GMO Research & AI, Inc., Annual General Meeting, Mar 18, 2025GMO Research & AI, Inc., Annual General Meeting, Mar 18, 2025.Upcoming Dividend • Dec 20Upcoming dividend of JP¥115 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 24 March 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.2%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.3%).お知らせ • Dec 14GMO Research & AI, Inc. to Report Fiscal Year 2024 Results on Feb 12, 2025GMO Research & AI, Inc. announced that they will report fiscal year 2024 results on Feb 12, 2025Reported Earnings • Nov 08Third quarter 2024 earnings released: JP¥8.57 loss per share (vs JP¥38.59 profit in 3Q 2023)Third quarter 2024 results: JP¥8.57 loss per share (down from JP¥38.59 profit in 3Q 2023). Revenue: JP¥1.19b (down 2.3% from 3Q 2023). Net loss: JP¥14.0m (down 122% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.お知らせ • Sep 27GMO Research & AI, Inc. to Report Q3, 2024 Results on Nov 06, 2024GMO Research & AI, Inc. announced that they will report Q3, 2024 results on Nov 06, 2024分析記事 • Aug 22Investors Can Find Comfort In GMO Research & AI's (TSE:3695) Earnings QualitySoft earnings didn't appear to concern GMO Research & AI, Inc.'s ( TSE:3695 ) shareholders over the last week. We did...Reported Earnings • Aug 09Second quarter 2024 earnings released: JP¥12.24 loss per share (vs JP¥11.64 profit in 2Q 2023)Second quarter 2024 results: JP¥12.24 loss per share (down from JP¥11.64 profit in 2Q 2023). Revenue: JP¥1.10b (down 4.3% from 2Q 2023). Net loss: JP¥20.0m (down 205% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has remained flat, which means it is well ahead of earnings.分析記事 • Aug 07GMO Research & AI, Inc. (TSE:3695) Investors Are Less Pessimistic Than ExpectedWhen close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 11x, you may consider GMO...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to JP¥2,258, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 16x in the Media industry in Japan. Total returns to shareholders of 7.6% over the past three years.お知らせ • Jun 28GMO Research & AI, Inc. to Report Q2, 2024 Results on Aug 06, 2024GMO Research & AI, Inc. announced that they will report Q2, 2024 results on Aug 06, 2024Reported Earnings • May 09First quarter 2024 earnings released: EPS: JP¥56.31 (vs JP¥82.69 in 1Q 2023)First quarter 2024 results: EPS: JP¥56.31 (down from JP¥82.69 in 1Q 2023). Revenue: JP¥1.36b (down 4.6% from 1Q 2023). Net income: JP¥92.0m (down 32% from 1Q 2023). Profit margin: 6.8% (down from 9.5% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.お知らせ • Mar 17GMO Research, Inc. to Report Q1, 2024 Results on May 08, 2024GMO Research, Inc. announced that they will report Q1, 2024 results on May 08, 2024Reported Earnings • Feb 07Full year 2023 earnings released: EPS: JP¥188 (vs JP¥218 in FY 2022)Full year 2023 results: EPS: JP¥188 (down from JP¥218 in FY 2022). Revenue: JP¥5.12b (down 1.6% from FY 2022). Net income: JP¥307.0m (down 14% from FY 2022). Profit margin: 6.0% (down from 6.8% in FY 2022). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 07GMO Research, Inc., Annual General Meeting, Mar 18, 2024GMO Research, Inc., Annual General Meeting, Mar 18, 2024.お知らせ • Dec 28GMO Research, Inc. to Report Fiscal Year 2023 Results on Feb 05, 2024GMO Research, Inc. announced that they will report fiscal year 2023 results on Feb 05, 2024Upcoming Dividend • Dec 21Upcoming dividend of JP¥115 per share at 4.0% yieldEligible shareholders must have bought the stock before 28 December 2023. Payment date: 25 March 2024. Payout ratio is a comfortable 70% but the company is not cash flow positive. Trailing yield: 4.0%. Within top quartile of Japanese dividend payers (3.5%). Higher than average of industry peers (2.7%).Reported Earnings • Nov 07Third quarter 2023 earnings released: EPS: JP¥38.59 (vs JP¥44.12 in 3Q 2022)Third quarter 2023 results: EPS: JP¥38.59 (down from JP¥44.12 in 3Q 2022). Revenue: JP¥1.22b (flat on 3Q 2022). Net income: JP¥63.0m (down 13% from 3Q 2022). Profit margin: 5.2% (down from 5.9% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 15% per year and the company’s share price has also increased by 15% per year.お知らせ • Sep 17GMO Research, Inc. to Report Q3, 2023 Results on Nov 06, 2023GMO Research, Inc. announced that they will report Q3, 2023 results on Nov 06, 2023New Risk • Aug 14New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 52% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (52% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (5.0% net profit margin). Market cap is less than US$100m (JP¥4.59b market cap, or US$31.7m).New Risk • Aug 05New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.0% Last year net profit margin: 8.2% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (469% cash payout ratio). Profit margins are more than 30% lower than last year (5.0% net profit margin). Market cap is less than US$100m (JP¥4.83b market cap, or US$34.1m).Reported Earnings • Aug 04Second quarter 2023 earnings released: EPS: JP¥11.64 (vs JP¥43.51 in 2Q 2022)Second quarter 2023 results: EPS: JP¥11.64 (down from JP¥43.51 in 2Q 2022). Revenue: JP¥1.15b (down 2.7% from 2Q 2022). Net income: JP¥19.0m (down 73% from 2Q 2022). Profit margin: 1.6% (down from 6.0% in 2Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 21% per year.お知らせ • Jun 28GMO Research, Inc. to Report Q2, 2023 Results on Aug 03, 2023GMO Research, Inc. announced that they will report Q2, 2023 results on Aug 03, 2023Reported Earnings • May 10First quarter 2023 earnings released: EPS: JP¥82.69 (vs JP¥107 in 1Q 2022)First quarter 2023 results: EPS: JP¥82.69 (down from JP¥107 in 1Q 2022). Revenue: JP¥1.43b (up 4.5% from 1Q 2022). Net income: JP¥135.0m (down 23% from 1Q 2022). Profit margin: 9.5% (down from 13% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 35% per year whereas the company’s share price has increased by 31% per year.Reported Earnings • Mar 28Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021)Full year 2022 results: EPS: JP¥218 (up from JP¥168 in FY 2021). Revenue: JP¥5.20b (up 27% from FY 2021). Net income: JP¥356.0m (up 30% from FY 2021). Profit margin: 6.8% (up from 6.7% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year whereas the company’s share price has increased by 45% per year.Valuation Update With 7 Day Price Move • Feb 13Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to JP¥3,060, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 14x in the Media industry in Japan. Total returns to shareholders of 121% over the past three years.Reported Earnings • Feb 12Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021)Full year 2022 results: EPS: JP¥218 (up from JP¥168 in FY 2021). Revenue: JP¥5.20b (up 27% from FY 2021). Net income: JP¥356.0m (up 30% from FY 2021). Profit margin: 6.8% (up from 6.7% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 08GMO Research, Inc., Annual General Meeting, Mar 22, 2023GMO Research, Inc., Annual General Meeting, Mar 22, 2023.Upcoming Dividend • Dec 22Upcoming dividend of JP¥116 per shareEligible shareholders must have bought the stock before 29 December 2022. Payment date: 22 March 2023. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.8%). In line with average of industry peers (2.7%).お知らせ • Dec 17GMO Research, Inc. to Report Fiscal Year 2022 Results on Feb 06, 2023GMO Research, Inc. announced that they will report fiscal year 2022 results on Feb 06, 2023Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 5 highly experienced directors. No independent directors (8 non-independent directors). Director Masashi Yasuda was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Nov 09Third quarter 2022 earnings released: EPS: JP¥44.12 (vs JP¥28.82 in 3Q 2021)Third quarter 2022 results: EPS: JP¥44.12 (up from JP¥28.82 in 3Q 2021). Revenue: JP¥1.22b (up 22% from 3Q 2021). Net income: JP¥72.0m (up 53% from 3Q 2021). Profit margin: 5.9% (up from 4.7% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth.お知らせ • Sep 18GMO Research, Inc. to Report Q3, 2022 Results on Nov 07, 2022GMO Research, Inc. announced that they will report Q3, 2022 results on Nov 07, 2022Valuation Update With 7 Day Price Move • Aug 11Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to JP¥3,740, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 15x in the Media industry in Japan. Total returns to shareholders of 116% over the past three years.Reported Earnings • Aug 05Second quarter 2022 earnings released: EPS: JP¥43.51 (vs JP¥14.11 in 2Q 2021)Second quarter 2022 results: EPS: JP¥43.51 (up from JP¥14.11 in 2Q 2021). Revenue: JP¥1.19b (up 33% from 2Q 2021). Net income: JP¥71.0m (up 209% from 2Q 2021). Profit margin: 6.0% (up from 2.6% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth.お知らせ • Jun 29GMO Research, Inc. to Report Q2, 2022 Results on Aug 04, 2022GMO Research, Inc. announced that they will report Q2, 2022 results on Aug 04, 2022Valuation Update With 7 Day Price Move • Jun 17Investor sentiment improved over the past weekAfter last week's 22% share price gain to JP¥4,080, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 13x in the Media industry in Japan. Total returns to shareholders of 148% over the past three years.Valuation Update With 7 Day Price Move • May 30Investor sentiment improved over the past weekAfter last week's 21% share price gain to JP¥3,095, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 14x in the Media industry in Japan. Total returns to shareholders of 109% over the past three years.お知らせ • May 12GMO Research, Inc. to Report Q1, 2022 Results on May 09, 2022GMO Research, Inc. announced that they will report Q1, 2022 results on May 09, 2022Reported Earnings • May 11First quarter 2022 earnings released: EPS: JP¥107 (vs JP¥64.39 in 1Q 2021)First quarter 2022 results: EPS: JP¥107 (up from JP¥64.39 in 1Q 2021). Revenue: JP¥1.37b (up 40% from 1Q 2021). Net income: JP¥175.0m (up 67% from 1Q 2021). Profit margin: 13% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 5 highly experienced directors. No independent directors (8 non-independent directors). Director Masashi Yasuda was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.お知らせ • Feb 09GMO Research, Inc., Annual General Meeting, Mar 18, 2022GMO Research, Inc., Annual General Meeting, Mar 18, 2022.Reported Earnings • Feb 08Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: JP¥168 (up from JP¥107 in FY 2020). Revenue: JP¥4.09b (up 20% from FY 2020). Net income: JP¥274.0m (up 57% from FY 2020). Profit margin: 6.7% (up from 5.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Dec 22Upcoming dividend of JP¥73.53 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 22 March 2022. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.9%).Reported Earnings • Nov 10Third quarter 2021 earnings released: EPS JP¥28.82 (vs JP¥25.76 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: JP¥999.0m (up 27% from 3Q 2020). Net income: JP¥47.0m (up 12% from 3Q 2020). Profit margin: 4.7% (down from 5.3% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to JP¥2,603, the stock trades at a trailing P/E ratio of 17x. Average trailing P/E is 24x in the Media industry in Japan. Total returns to shareholders of 66% over the past three years.Reported Earnings • May 08First quarter 2021 earnings released: EPS JP¥64.39 (vs JP¥19.01 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: JP¥976.0m (up 6.7% from 1Q 2020). Net income: JP¥105.0m (up 239% from 1Q 2020). Profit margin: 11% (up from 3.4% in 1Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 07Investor sentiment improved over the past weekAfter last week's 15% share price gain to JP¥2,050, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 23x in the Media industry in Japan. Total returns to shareholders of 18% over the past three years.お知らせ • Apr 29GMO Research, Inc. to launch new service brand “MO Lite”GMO Research, Inc. has rolled out a new initiative to support companies in conducting online research projects with the fastest and most cost-effective turnaround in APAC. There is an increasing demand for DIY market research tools that allow companies to conduct survey research remotely and at low costs. But when a company really starts to plan a research project, there are some common obstacles. Firstly, the targeted audience is limited to the company’s own service and/or product line, so the company cannot collect a larger number of responses. Secondly, recruiting people for a survey is a time-consuming and costly process. And lastly, localizing questionnaires, ensuring they align with local law, and checking that the contents address the cultural and linguistic background correctly takes a great deal of effort. To address these issues, GMO Research has developed “MO Lite”, a new service that enables companies to link their own using DIY market research tools to recruit survey respondents directly from one of the largest pool of panelists in APAC, with a price less as USD 10 cent per question, that comes with full support from APAC local experts. USD 300 minimum fee will be included.お知らせ • Feb 11GMO Research, Inc., Annual General Meeting, Mar 19, 2021GMO Research, Inc., Annual General Meeting, Mar 19, 2021.Reported Earnings • Feb 11Full year 2020 earnings released: EPS JP¥107 (vs JP¥83.74 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: JP¥3.39b (up 3.2% from FY 2019). Net income: JP¥175.0m (up 28% from FY 2019). Profit margin: 5.2% (up from 4.2% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 1% per year.Is New 90 Day High Low • Dec 29New 90-day low: JP¥1,645The company is down 3.0% from its price of JP¥1,702 on 30 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Media industry, which is up 2.0% over the same period.お知らせ • Oct 04GMO Research, Inc. to Report Q3, 2020 Results on Nov 06, 2020GMO Research, Inc. announced that they will report Q3, 2020 results on Nov 06, 2020お知らせ • Jun 28GMO Research, Inc. to Report Q2, 2020 Results on Aug 07, 2020GMO Research, Inc. announced that they will report Q2, 2020 results on Aug 07, 2020株主還元3695JP MediaJP 市場7D-1.3%0.8%1.2%1Y-32.9%4.4%42.1%株主還元を見る業界別リターン: 3695過去 1 年間で4.4 % の収益を上げたJP Media業界を下回りました。リターン対市場: 3695は、過去 1 年間で42.1 % のリターンを上げたJP市場を下回りました。価格変動Is 3695's price volatile compared to industry and market?3695 volatility3695 Average Weekly Movement3.5%Media Industry Average Movement5.1%Market Average Movement5.0%10% most volatile stocks in JP Market9.6%10% least volatile stocks in JP Market2.5%安定した株価: 3695 、 JP市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 3695の 週次ボラティリティ ( 3% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2002199Takehiro Ogitagmo-research.aiGMOプロダクトプラットフォーム株式会社は、日本、アジア、そして世界で視聴者参加型プラットフォームを提供しています。インターネットを活用した市場調査、アンケート調査、集計・分析業務を行っている。DIY調査ツールからプロフェッショナル調査プラットフォームまで幅広いソリューションを提供する「ASIACloud Panel」、セルフサービス型オンライン調査プラットフォーム「GMOMarketObserver」、人工知能を活用したパッケージ型調査サービス「GMOAsk」、ユーザー満足度の声を分析・公開する「GMOCustomer Satisfaction Ranking」、AIを活用したより深い行動インサイトのための調査モジュール「DepthX by GMO」などを提供している。また、「TownWiFi byGMO」、「Cashmart byGMO」、「シフト手帳 byGMO」といった独自のスマートフォンアプリを通じた広告サービスも提供している。旧社名はGMOリサーチ＆AI株式会社で、2025年10月にGMOプロダクトプラットフォーム株式会社に商号変更した。GMOプロダクトプラットフォーム株式会社は2002年に設立され、東京に本社を置いている。GMOインターネットグループの子会社である。もっと見るGMO Product Platform, Inc. 基礎のまとめGMO Product Platform の収益と売上を時価総額と比較するとどうか。3695 基礎統計学時価総額JP¥7.60b収益（TTM）JP¥414.00m売上高(TTM)JP¥7.50b18.4xPER（株価収益率1.0xP/Sレシオ3695 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計3695 損益計算書（TTM）収益JP¥7.50b売上原価JP¥3.08b売上総利益JP¥4.41bその他の費用JP¥4.00b収益JP¥414.00m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）94.02グロス・マージン58.86%純利益率5.52%有利子負債／自己資本比率25.6%3695 の長期的なパフォーマンスは？過去の実績と比較を見る配当金3.7%現在の配当利回り63%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 16:30終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋GMO Product Platform, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Yu TokudaDaiwa Securities Co. Ltd.Kaname FujitaIchiyoshi Research Institute Inc.Ikuo ShibataThe Stock Research Center
Reported Earnings • May 13First quarter 2026 earnings released: EPS: JP¥43.61 (vs JP¥41.01 loss in 1Q 2025)First quarter 2026 results: EPS: JP¥43.61 (up from JP¥41.01 loss in 1Q 2025). Revenue: JP¥2.00b (up 52% from 1Q 2025). Net income: JP¥192.0m (up JP¥259.0m from 1Q 2025). Profit margin: 9.6% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to JP¥1,706, the stock trades at a trailing P/E ratio of 48.5x. Average trailing P/E is 16x in the Media industry in Japan. Total loss to shareholders of 38% over the past three years.
New Risk • Feb 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Share price has been volatile over the past 3 months (5.5% average weekly change). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥8.10b market cap, or US$52.8m).
Reported Earnings • Feb 11Full year 2025 earnings released: EPS: JP¥41.66 (vs JP¥112 in FY 2024)Full year 2025 results: EPS: JP¥41.66 (down from JP¥112 in FY 2024). Revenue: JP¥6.82b (up 36% from FY 2024). Net income: JP¥155.0m (down 15% from FY 2024). Profit margin: 2.3% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
New Risk • Feb 11New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.3% Last year net profit margin: 3.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥9.03b market cap, or US$59.0m).
お知らせ • Feb 10GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026.
Reported Earnings • May 13First quarter 2026 earnings released: EPS: JP¥43.61 (vs JP¥41.01 loss in 1Q 2025)First quarter 2026 results: EPS: JP¥43.61 (up from JP¥41.01 loss in 1Q 2025). Revenue: JP¥2.00b (up 52% from 1Q 2025). Net income: JP¥192.0m (up JP¥259.0m from 1Q 2025). Profit margin: 9.6% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to JP¥1,706, the stock trades at a trailing P/E ratio of 48.5x. Average trailing P/E is 16x in the Media industry in Japan. Total loss to shareholders of 38% over the past three years.
New Risk • Feb 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Share price has been volatile over the past 3 months (5.5% average weekly change). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥8.10b market cap, or US$52.8m).
Reported Earnings • Feb 11Full year 2025 earnings released: EPS: JP¥41.66 (vs JP¥112 in FY 2024)Full year 2025 results: EPS: JP¥41.66 (down from JP¥112 in FY 2024). Revenue: JP¥6.82b (up 36% from FY 2024). Net income: JP¥155.0m (down 15% from FY 2024). Profit margin: 2.3% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
New Risk • Feb 11New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.3% Last year net profit margin: 3.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥9.03b market cap, or US$59.0m).
お知らせ • Feb 10GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026.
お知らせ • Dec 27GMO Product Platform, Inc. to Report Fiscal Year 2025 Results on Feb 10, 2026GMO Product Platform, Inc. announced that they will report fiscal year 2025 results on Feb 10, 2026
Upcoming Dividend • Dec 22Upcoming dividend of JP¥34.58 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 23 March 2026. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 1.6%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (1.7%).
お知らせ • Dec 17GMO Product Platform, Inc. (TSE:3695) agreed to acquire 53.60% stake in STOCK POINT Inc. from Credit Saison Co., Ltd. (TSE:8253), KITS Co., Ltd and Kiyomi Tsuchiya for approximately ¥360 million.GMO Product Platform, Inc. (TSE:3695) agreed to acquire 53.60% stake in STOCK POINT Inc. from Credit Saison Co., Ltd. (TSE:8253), KITS Co., Ltd and Kiyomi Tsuchiya for approximately ¥360 million on December 15, 2025. A cash consideration of ¥361 million will be paid by GMO Product Platform, Inc. The scheduled contract execution date is December 16, 2025. Prior to the share transfer execution date, we may acquire additional shares of STOCK POINT Inc. held by other individuals and corporations. In this case, the maximum acquisition price will be ¥564 million, and the maximum number of shares to be acquired will be 1,324 shares and the maximum ownership ratio will be 82.5%. Additional disclosure is planned once the acquisition price and number of shares for the additional acquisition are finalized. For the period ending March 31, 2025, STOCK POINT Inc. reported total revenue of ¥374.18 million, operating loss of ¥231.81 million and net income of ¥200.21 million. As of March 31, 2025, STOCK POINT Inc. reported total assets of ¥2.28 billion and total common equity of ¥214.51 million. The expected completion of the transaction is December 26, 2025.
Buy Or Sell Opportunity • Dec 04Now 21% overvaluedOver the last 90 days, the stock has fallen 2.4% to JP¥2,159. The fair value is estimated to be JP¥1,782, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.4% over the last 3 years. Earnings per share has declined by 48%.
Reported Earnings • Nov 15Third quarter 2025 earnings released: EPS: JP¥23.99 (vs JP¥8.57 loss in 3Q 2024)Third quarter 2025 results: EPS: JP¥23.99 (up from JP¥8.57 loss in 3Q 2024). Revenue: JP¥1.75b (up 47% from 3Q 2024). Net income: JP¥106.0m (up JP¥120.0m from 3Q 2024). Profit margin: 6.1% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.
お知らせ • Sep 17GMO Research & AI, Inc. to Report Q3, 2025 Results on Nov 12, 2025GMO Research & AI, Inc. announced that they will report Q3, 2025 results on Nov 12, 2025
Reported Earnings • Aug 08Second quarter 2025 earnings released: EPS: JP¥12.67 (vs JP¥12.24 loss in 2Q 2024)Second quarter 2025 results: EPS: JP¥12.67 (up from JP¥12.24 loss in 2Q 2024). Revenue: JP¥1.85b (up 68% from 2Q 2024). Net income: JP¥56.0m (up JP¥76.0m from 2Q 2024). Profit margin: 3.0% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.
お知らせ • Jun 27GMO Research & AI, Inc. to Report Q2, 2025 Results on Aug 07, 2025GMO Research & AI, Inc. announced that they will report Q2, 2025 results on Aug 07, 2025
New Risk • May 17New major risk - Revenue and earnings growthEarnings have declined by 0.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Dividend per share is over 7x earnings per share. Cash payout ratio: 447% Earnings have declined by 0.4% per year over the past 5 years. Shareholders have been substantially diluted in the past year (169% increase in shares outstanding). Minor Risks Profit margins are more than 30% lower than last year (0.5% net profit margin). Market cap is less than US$100m (JP¥11.1b market cap, or US$76.0m).
Reported Earnings • May 17First quarter 2025 earnings released: JP¥41.01 loss per share (vs JP¥56.35 profit in 1Q 2024)First quarter 2025 results: JP¥41.01 loss per share (down from JP¥56.35 profit in 1Q 2024). Revenue: JP¥1.32b (down 3.2% from 1Q 2024). Net loss: JP¥67.0m (down 173% from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • May 15Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to JP¥2,374, the stock trades at a trailing P/E ratio of 57.1x. Average trailing P/E is 17x in the Media industry in Japan. Total returns to shareholders of 4.5% over the past three years.
New Risk • Apr 18New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 169% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 103% Cash payout ratio: 447% Shareholders have been substantially diluted in the past year (169% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (3.6% net profit margin). Market cap is less than US$100m (JP¥12.2b market cap, or US$85.7m).
分析記事 • Apr 09Returns On Capital At GMO Research & AI (TSE:3695) Paint A Concerning PictureWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
お知らせ • Mar 08GMO Research & AI, Inc. to Report Q1, 2025 Results on May 12, 2025GMO Research & AI, Inc. announced that they will report Q1, 2025 results on May 12, 2025
New Risk • Feb 15New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 127% Cash payout ratio: 166% Dividend yield: 4.1% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.6% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 127% Cash payout ratio: 166% Minor Risks Profit margins are more than 30% lower than last year (3.6% net profit margin). Market cap is less than US$100m (JP¥4.57b market cap, or US$30.0m).
Reported Earnings • Feb 14Full year 2024 earnings released: EPS: JP¥112 (vs JP¥188 in FY 2023)Full year 2024 results: EPS: JP¥112 (down from JP¥188 in FY 2023). Revenue: JP¥5.03b (down 1.8% from FY 2023). Net income: JP¥183.0m (down 40% from FY 2023). Profit margin: 3.6% (down from 6.0% in FY 2023). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
分析記事 • Feb 13GMO Research & AI, Inc.'s (TSE:3695) 25% Share Price Surge Not Quite Adding UpGMO Research & AI, Inc. ( TSE:3695 ) shares have had a really impressive month, gaining 25% after a shaky period...
分析記事 • Feb 13Subdued Growth No Barrier To GMO Research & AI, Inc. (TSE:3695) With Shares Advancing 25%GMO Research & AI, Inc. ( TSE:3695 ) shares have had a really impressive month, gaining 25% after a shaky period...
New Risk • Feb 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (127% payout ratio). Share price has been volatile over the past 3 months (7.5% average weekly change). Profit margins are more than 30% lower than last year (3.0% net profit margin). Market cap is less than US$100m (JP¥4.69b market cap, or US$30.5m).
Valuation Update With 7 Day Price Move • Feb 13Investor sentiment improves as stock rises 20%After last week's 20% share price gain to JP¥2,870, the stock trades at a trailing P/E ratio of 31.7x. Average trailing P/E is 17x in the Media industry in Japan. Total returns to shareholders of 38% over the past three years.
お知らせ • Feb 12GMO Research & AI, Inc., Annual General Meeting, Mar 18, 2025GMO Research & AI, Inc., Annual General Meeting, Mar 18, 2025.
Upcoming Dividend • Dec 20Upcoming dividend of JP¥115 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 24 March 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.2%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.3%).
お知らせ • Dec 14GMO Research & AI, Inc. to Report Fiscal Year 2024 Results on Feb 12, 2025GMO Research & AI, Inc. announced that they will report fiscal year 2024 results on Feb 12, 2025
Reported Earnings • Nov 08Third quarter 2024 earnings released: JP¥8.57 loss per share (vs JP¥38.59 profit in 3Q 2023)Third quarter 2024 results: JP¥8.57 loss per share (down from JP¥38.59 profit in 3Q 2023). Revenue: JP¥1.19b (down 2.3% from 3Q 2023). Net loss: JP¥14.0m (down 122% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
お知らせ • Sep 27GMO Research & AI, Inc. to Report Q3, 2024 Results on Nov 06, 2024GMO Research & AI, Inc. announced that they will report Q3, 2024 results on Nov 06, 2024
分析記事 • Aug 22Investors Can Find Comfort In GMO Research & AI's (TSE:3695) Earnings QualitySoft earnings didn't appear to concern GMO Research & AI, Inc.'s ( TSE:3695 ) shareholders over the last week. We did...
Reported Earnings • Aug 09Second quarter 2024 earnings released: JP¥12.24 loss per share (vs JP¥11.64 profit in 2Q 2023)Second quarter 2024 results: JP¥12.24 loss per share (down from JP¥11.64 profit in 2Q 2023). Revenue: JP¥1.10b (down 4.3% from 2Q 2023). Net loss: JP¥20.0m (down 205% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
分析記事 • Aug 07GMO Research & AI, Inc. (TSE:3695) Investors Are Less Pessimistic Than ExpectedWhen close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 11x, you may consider GMO...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to JP¥2,258, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 16x in the Media industry in Japan. Total returns to shareholders of 7.6% over the past three years.
お知らせ • Jun 28GMO Research & AI, Inc. to Report Q2, 2024 Results on Aug 06, 2024GMO Research & AI, Inc. announced that they will report Q2, 2024 results on Aug 06, 2024
Reported Earnings • May 09First quarter 2024 earnings released: EPS: JP¥56.31 (vs JP¥82.69 in 1Q 2023)First quarter 2024 results: EPS: JP¥56.31 (down from JP¥82.69 in 1Q 2023). Revenue: JP¥1.36b (down 4.6% from 1Q 2023). Net income: JP¥92.0m (down 32% from 1Q 2023). Profit margin: 6.8% (down from 9.5% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
お知らせ • Mar 17GMO Research, Inc. to Report Q1, 2024 Results on May 08, 2024GMO Research, Inc. announced that they will report Q1, 2024 results on May 08, 2024
Reported Earnings • Feb 07Full year 2023 earnings released: EPS: JP¥188 (vs JP¥218 in FY 2022)Full year 2023 results: EPS: JP¥188 (down from JP¥218 in FY 2022). Revenue: JP¥5.12b (down 1.6% from FY 2022). Net income: JP¥307.0m (down 14% from FY 2022). Profit margin: 6.0% (down from 6.8% in FY 2022). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 07GMO Research, Inc., Annual General Meeting, Mar 18, 2024GMO Research, Inc., Annual General Meeting, Mar 18, 2024.
お知らせ • Dec 28GMO Research, Inc. to Report Fiscal Year 2023 Results on Feb 05, 2024GMO Research, Inc. announced that they will report fiscal year 2023 results on Feb 05, 2024
Upcoming Dividend • Dec 21Upcoming dividend of JP¥115 per share at 4.0% yieldEligible shareholders must have bought the stock before 28 December 2023. Payment date: 25 March 2024. Payout ratio is a comfortable 70% but the company is not cash flow positive. Trailing yield: 4.0%. Within top quartile of Japanese dividend payers (3.5%). Higher than average of industry peers (2.7%).
Reported Earnings • Nov 07Third quarter 2023 earnings released: EPS: JP¥38.59 (vs JP¥44.12 in 3Q 2022)Third quarter 2023 results: EPS: JP¥38.59 (down from JP¥44.12 in 3Q 2022). Revenue: JP¥1.22b (flat on 3Q 2022). Net income: JP¥63.0m (down 13% from 3Q 2022). Profit margin: 5.2% (down from 5.9% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 15% per year and the company’s share price has also increased by 15% per year.
お知らせ • Sep 17GMO Research, Inc. to Report Q3, 2023 Results on Nov 06, 2023GMO Research, Inc. announced that they will report Q3, 2023 results on Nov 06, 2023
New Risk • Aug 14New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 52% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (52% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (5.0% net profit margin). Market cap is less than US$100m (JP¥4.59b market cap, or US$31.7m).
New Risk • Aug 05New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.0% Last year net profit margin: 8.2% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (469% cash payout ratio). Profit margins are more than 30% lower than last year (5.0% net profit margin). Market cap is less than US$100m (JP¥4.83b market cap, or US$34.1m).
Reported Earnings • Aug 04Second quarter 2023 earnings released: EPS: JP¥11.64 (vs JP¥43.51 in 2Q 2022)Second quarter 2023 results: EPS: JP¥11.64 (down from JP¥43.51 in 2Q 2022). Revenue: JP¥1.15b (down 2.7% from 2Q 2022). Net income: JP¥19.0m (down 73% from 2Q 2022). Profit margin: 1.6% (down from 6.0% in 2Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 21% per year.
お知らせ • Jun 28GMO Research, Inc. to Report Q2, 2023 Results on Aug 03, 2023GMO Research, Inc. announced that they will report Q2, 2023 results on Aug 03, 2023
Reported Earnings • May 10First quarter 2023 earnings released: EPS: JP¥82.69 (vs JP¥107 in 1Q 2022)First quarter 2023 results: EPS: JP¥82.69 (down from JP¥107 in 1Q 2022). Revenue: JP¥1.43b (up 4.5% from 1Q 2022). Net income: JP¥135.0m (down 23% from 1Q 2022). Profit margin: 9.5% (down from 13% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 35% per year whereas the company’s share price has increased by 31% per year.
Reported Earnings • Mar 28Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021)Full year 2022 results: EPS: JP¥218 (up from JP¥168 in FY 2021). Revenue: JP¥5.20b (up 27% from FY 2021). Net income: JP¥356.0m (up 30% from FY 2021). Profit margin: 6.8% (up from 6.7% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year whereas the company’s share price has increased by 45% per year.
Valuation Update With 7 Day Price Move • Feb 13Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to JP¥3,060, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 14x in the Media industry in Japan. Total returns to shareholders of 121% over the past three years.
Reported Earnings • Feb 12Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021)Full year 2022 results: EPS: JP¥218 (up from JP¥168 in FY 2021). Revenue: JP¥5.20b (up 27% from FY 2021). Net income: JP¥356.0m (up 30% from FY 2021). Profit margin: 6.8% (up from 6.7% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 08GMO Research, Inc., Annual General Meeting, Mar 22, 2023GMO Research, Inc., Annual General Meeting, Mar 22, 2023.
Upcoming Dividend • Dec 22Upcoming dividend of JP¥116 per shareEligible shareholders must have bought the stock before 29 December 2022. Payment date: 22 March 2023. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.8%). In line with average of industry peers (2.7%).
お知らせ • Dec 17GMO Research, Inc. to Report Fiscal Year 2022 Results on Feb 06, 2023GMO Research, Inc. announced that they will report fiscal year 2022 results on Feb 06, 2023
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 5 highly experienced directors. No independent directors (8 non-independent directors). Director Masashi Yasuda was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Nov 09Third quarter 2022 earnings released: EPS: JP¥44.12 (vs JP¥28.82 in 3Q 2021)Third quarter 2022 results: EPS: JP¥44.12 (up from JP¥28.82 in 3Q 2021). Revenue: JP¥1.22b (up 22% from 3Q 2021). Net income: JP¥72.0m (up 53% from 3Q 2021). Profit margin: 5.9% (up from 4.7% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth.
お知らせ • Sep 18GMO Research, Inc. to Report Q3, 2022 Results on Nov 07, 2022GMO Research, Inc. announced that they will report Q3, 2022 results on Nov 07, 2022
Valuation Update With 7 Day Price Move • Aug 11Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to JP¥3,740, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 15x in the Media industry in Japan. Total returns to shareholders of 116% over the past three years.
Reported Earnings • Aug 05Second quarter 2022 earnings released: EPS: JP¥43.51 (vs JP¥14.11 in 2Q 2021)Second quarter 2022 results: EPS: JP¥43.51 (up from JP¥14.11 in 2Q 2021). Revenue: JP¥1.19b (up 33% from 2Q 2021). Net income: JP¥71.0m (up 209% from 2Q 2021). Profit margin: 6.0% (up from 2.6% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth.
お知らせ • Jun 29GMO Research, Inc. to Report Q2, 2022 Results on Aug 04, 2022GMO Research, Inc. announced that they will report Q2, 2022 results on Aug 04, 2022
Valuation Update With 7 Day Price Move • Jun 17Investor sentiment improved over the past weekAfter last week's 22% share price gain to JP¥4,080, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 13x in the Media industry in Japan. Total returns to shareholders of 148% over the past three years.
Valuation Update With 7 Day Price Move • May 30Investor sentiment improved over the past weekAfter last week's 21% share price gain to JP¥3,095, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 14x in the Media industry in Japan. Total returns to shareholders of 109% over the past three years.
お知らせ • May 12GMO Research, Inc. to Report Q1, 2022 Results on May 09, 2022GMO Research, Inc. announced that they will report Q1, 2022 results on May 09, 2022
Reported Earnings • May 11First quarter 2022 earnings released: EPS: JP¥107 (vs JP¥64.39 in 1Q 2021)First quarter 2022 results: EPS: JP¥107 (up from JP¥64.39 in 1Q 2021). Revenue: JP¥1.37b (up 40% from 1Q 2021). Net income: JP¥175.0m (up 67% from 1Q 2021). Profit margin: 13% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 5 highly experienced directors. No independent directors (8 non-independent directors). Director Masashi Yasuda was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
お知らせ • Feb 09GMO Research, Inc., Annual General Meeting, Mar 18, 2022GMO Research, Inc., Annual General Meeting, Mar 18, 2022.
Reported Earnings • Feb 08Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: JP¥168 (up from JP¥107 in FY 2020). Revenue: JP¥4.09b (up 20% from FY 2020). Net income: JP¥274.0m (up 57% from FY 2020). Profit margin: 6.7% (up from 5.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Dec 22Upcoming dividend of JP¥73.53 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 22 March 2022. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.9%).
Reported Earnings • Nov 10Third quarter 2021 earnings released: EPS JP¥28.82 (vs JP¥25.76 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: JP¥999.0m (up 27% from 3Q 2020). Net income: JP¥47.0m (up 12% from 3Q 2020). Profit margin: 4.7% (down from 5.3% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to JP¥2,603, the stock trades at a trailing P/E ratio of 17x. Average trailing P/E is 24x in the Media industry in Japan. Total returns to shareholders of 66% over the past three years.
Reported Earnings • May 08First quarter 2021 earnings released: EPS JP¥64.39 (vs JP¥19.01 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: JP¥976.0m (up 6.7% from 1Q 2020). Net income: JP¥105.0m (up 239% from 1Q 2020). Profit margin: 11% (up from 3.4% in 1Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 07Investor sentiment improved over the past weekAfter last week's 15% share price gain to JP¥2,050, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 23x in the Media industry in Japan. Total returns to shareholders of 18% over the past three years.
お知らせ • Apr 29GMO Research, Inc. to launch new service brand “MO Lite”GMO Research, Inc. has rolled out a new initiative to support companies in conducting online research projects with the fastest and most cost-effective turnaround in APAC. There is an increasing demand for DIY market research tools that allow companies to conduct survey research remotely and at low costs. But when a company really starts to plan a research project, there are some common obstacles. Firstly, the targeted audience is limited to the company’s own service and/or product line, so the company cannot collect a larger number of responses. Secondly, recruiting people for a survey is a time-consuming and costly process. And lastly, localizing questionnaires, ensuring they align with local law, and checking that the contents address the cultural and linguistic background correctly takes a great deal of effort. To address these issues, GMO Research has developed “MO Lite”, a new service that enables companies to link their own using DIY market research tools to recruit survey respondents directly from one of the largest pool of panelists in APAC, with a price less as USD 10 cent per question, that comes with full support from APAC local experts. USD 300 minimum fee will be included.
お知らせ • Feb 11GMO Research, Inc., Annual General Meeting, Mar 19, 2021GMO Research, Inc., Annual General Meeting, Mar 19, 2021.
Reported Earnings • Feb 11Full year 2020 earnings released: EPS JP¥107 (vs JP¥83.74 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: JP¥3.39b (up 3.2% from FY 2019). Net income: JP¥175.0m (up 28% from FY 2019). Profit margin: 5.2% (up from 4.2% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 1% per year.
Is New 90 Day High Low • Dec 29New 90-day low: JP¥1,645The company is down 3.0% from its price of JP¥1,702 on 30 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Media industry, which is up 2.0% over the same period.
お知らせ • Oct 04GMO Research, Inc. to Report Q3, 2020 Results on Nov 06, 2020GMO Research, Inc. announced that they will report Q3, 2020 results on Nov 06, 2020
お知らせ • Jun 28GMO Research, Inc. to Report Q2, 2020 Results on Aug 07, 2020GMO Research, Inc. announced that they will report Q2, 2020 results on Aug 07, 2020
